Beta Drugs Ltd
- Market Cap ₹ 116 Cr.
- Current Price ₹ 121
- High / Low ₹ 141 / 37.0
- Stock P/E 12.3
- Book Value ₹ 59.4
- Dividend Yield 0.00 %
- ROCE 20.7 %
- ROE 19.3 %
- Face Value ₹ 10.0
Pros
- No pros found. Suggest something.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Loading peers table ...
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Operating Profit |
OPM % |
Other Income |
Interest |
Depreciation |
Profit before tax |
Tax % |
Net Profit |
EPS in Rs |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|
50.57 | 65.93 | 90.81 | |
41.11 | 54.12 | 72.88 | |
Operating Profit | 9.46 | 11.81 | 17.93 |
OPM % | 18.71% | 17.91% | 19.74% |
Other Income | 0.24 | 0.37 | 0.39 |
Interest | 1.01 | 1.43 | 2.59 |
Depreciation | 1.85 | 2.84 | 3.76 |
Profit before tax | 6.84 | 7.91 | 11.97 |
Tax % | 1.02% | -1.77% | 21.39% |
Net Profit | 6.76 | 8.04 | 9.42 |
EPS in Rs | 7.82 | 9.30 | 9.80 |
Dividend Payout % | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 38% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 17% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -8% |
1 Year: | 103% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 19% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|
8.65 | 8.65 | 9.61 | |
Reserves | 24.23 | 32.27 | 47.50 |
Borrowings | 7.50 | 19.97 | 22.57 |
9.20 | 21.65 | 27.50 | |
Total Liabilities | 49.58 | 82.54 | 107.18 |
13.19 | 17.67 | 43.82 | |
CWIP | 1.35 | 14.69 | 0.08 |
Investments | 0.00 | 0.35 | 0.35 |
35.04 | 49.83 | 62.93 | |
Total Assets | 49.58 | 82.54 | 107.18 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|
17.10 | 0.11 | 8.41 | |
-10.79 | -20.78 | -15.05 | |
5.45 | 12.07 | 8.73 | |
Net Cash Flow | 11.76 | -8.61 | 2.09 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|
ROCE % | 18.45% | 20.74% | |
Debtor Days | 104.22 | 138.57 | 128.34 |
Inventory Turnover | 5.64 | 4.28 |
Documents
Add documentRecent announcements
- Updates Feb. 17, 2021
- Outcome of Board Meeting Jan. 27, 2021
- Outcome of Board Meeting Jan. 27, 2021
- Updates Nov. 17, 2020
- Updates Nov. 2, 2020
View all